Clinical trial

Metastasis-directed Therapy for Oligometastases of Breast Cancer

NCT06135714

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Systemic therapy for 12 weeks after primary registration Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Radiation therapy (SBRT/conventional RT) Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Surgery Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Same systemic therapy after secondary registration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Metastasis-directed Therapy for Oligometastases of Breast Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-11-08

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Oligometastasisunresolved

Metastatic Breast Cancerunresolved

Interventions

Systemic therapy for 12 weeks after primary registrationDRUG

Radiation therapy (SBRT/conventional RT)PROCEDURE

SurgeryPROCEDURE

Same systemic therapy after secondary registrationDRUG

Sponsors & collaborators

Tokyo Medical and Dental Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06135714 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.